Citations

Institution: Mayo Clinic Clear

Showing 10 of 108135 citations.

FISHing for pancreatobiliary tract malignancy in endoscopic brushings enhances the sensitivity of routine cytology
Kipp, Benjamin R. , Halling, Kevin C. , Clayton, Amy C., Fritcher, Emily G. Barr

Cytopathology | July 30, 2014 | Volume: 25 | Issue: 5 | Pages: 288-301

10.1111/cyt.12170 | PMID 25073411 Get It

Pancreatobiliary tract carcinoma is a lethal disease with low survival rates and limited treatment options. Diagnosis is complicated by benign conditions that can mimic malignancy on radiological studies (e.g. primary sclerosing cholangitis or PSC) and the suboptimal sensitivity of endoscopic biopsy/brushings obtained by endoscopic retrograde cholangiopancreatography (ERCP). The detection of multiple chromosomal gains by fluorescence in situ hybridization (FISH), referred to as polysomy, has demonstrated improved sensitivity over routine cytological evaluation. The evaluation of brushings by both routine cytology and FISH in our cytopathology laboratory has been in clinical practice since 2003. Strong morphological and screening skills enable cytotechnologists to become proficient in the assessment of FISH slides, which translates into cost and time savings. Multiple reports from various institutions have demonstrated the utility of FISH for patients with and without PSC. The incorporation of routine cytology and FISH results into the management algorithm for patients under suspicion for pancreatobiliary malignancy is a testament to the clinical success of these cytological assays.
Effects of delayed gastric emptying on postprandial glucose kinetics, insulin sensitivity, and β-cell function
Hinshaw, Ling , Schiavon, Michele , Mallad, Ashwini , Man, Chiara Dalla , Basu, Rita , Bharucha, Adil E. , Carter, Rickey E. , Basu, Ananda , Kudva, Yogish C. , Cobelli, Claudio , Dalla Man, Chiara , Carter, Rickey E , Schiavon, Michele

American Journal of Physiology-Endocrinology and Metabolism | July 30, 2014 | Volume: 307 | Issue: 6 | Pages: E494-E502

10.1152/ajpendo.00199.2014 | PMID 25074985 Get It

Controlling meal-related glucose excursions continues to be a therapeutic challenge in diabetes mellitus. Mechanistic reasons for this need to be understood better to develop appropriate therapies. To investigate delayed gastric emptying effects on postprandial glucose turnover, insulin sensitivity, and β-cell responsivity and function, as a feasibility study prior to studying patients with type 1 diabetes, we used the triple tracer technique C-peptide and oral minimal model approach in healthy subjects. A single dose of 30 μg of pramlintide administered at the start of a mixed meal was used to delay gastric emptying rates. With delayed gastric emptying rates, peak rate of meal glucose appearance was delayed, and rate of endogenous glucose production (EGP) was lower. C-peptide and oral minimal models enabled the assessments of β-cell function, insulin sensitivity, and β-cell responsivity simultaneously. Delayed gastric emptying induced by pramlintide improved total insulin sensitivity and decreased total β-cell responsivity. However, β-cell function as measured by total disposition index did not change. The improved whole body insulin sensitivity coupled with lower rate of appearance of EGP with delayed gastric emptying provides experimental proof of the importance of evaluating pramlintide in artificial endocrine pancreas approaches to reduce postprandial blood glucose variability in patients with type 1 diabetes.
Differential effects of insulin sensitization and insulin provision treatment strategies on concentrations of circulating adipokines in patients with diabetes and coronary artery disease in the BARI 2D trial
Wołk, Robert , Bertolet, Marnie , Brooks, Maria M. , Sobel, Burton E., Frye, Robert L. , Singh, Prachi , Calvin, Andrew D. , Rutter, Martin K. , Mooradian, Arshag D. , group, for the BARI 2D study, Pratley, Richard E. , Somers, Virend K. , group, for the BARI 2D study, Singh, Prachi , Calvin, Andrew D

European Journal of Preventive Cardiology | July 30, 2014 | Volume: 23 | Issue: 1 | Pages: 50-58

10.1177/2047487314544046 | PMID 25073857 Get It

Effects of aspirin & simvastatin and aspirin, simvastatin, & lipoic acid on heme oxygenase‐1 in healthy human subjects
Bharucha, Adil E. , Choi, Kyoung Moo , Saw, Jessica J. , Gibbons, Simon J. , Farrugia, Gianrico , Carlson, David A. , Zinsmeister, Alan R., Saw, J J , Gibbons, S J

Neurogastroenterology & Motility | July 30, 2014 | Volume: 26 | Issue: 10 | Pages: 1437-1442

10.1111/nmo.12404 | PMID 25093998 Get It

AbstractBackgroundHeme oxygenase 1 (HO‐1) degrades heme and protects against oxidative stress. In vitro and animal models suggest that HO‐1 is beneficial in several diseases (e.g., postoperative ileus, gastroparesis, acute pancreatitis, and colitis). However, the only drugs (i.e., hemin and heme arginate) which pharmacologically upregulate HO‐1 in humans are expensive and can only be administered intravenously. Our aims were to compare the effects of placebo, aspirin, and simvastatin alone, and with α‐lipoic acid, on HO‐1 protein concentration and activity in humans.MethodsThis randomized, double‐blind, placebo‐controlled study compared the effects of three oral regimens administered for 7 days, i.e., placebo; aspirin (325 mg twice daily) and simvastatin (40 mg twice daily); aspirin, simvastatin, and the sodium salt of R‐ α‐lipoic acid (NaRLA, 600 mg three times daily) on markers of HO‐1 activation (i.e., plasma HO‐1 protein concentration and venous monocyte HO‐1 protein activity) in 18 healthy subjects (14 females). Markers of HO‐1 activation were evaluated at baseline, days 2, and 7.Key ResultsBaseline HO‐1 protein concentrations and activity were similar among the three groups. Compared to placebo, aspirin and simvastatin combined, or together with NaRLA did not affect HO‐1 protein concentration or activity at 2 or 7 days. HO‐1 protein concentrations and activity were correlated on day 7 (r = 0.75, p = 0.0004) but not at baseline and on day 2.Conclusions & InferencesAt therapeutic doses, aspirin, simvastatin, and α‐lipoic acid do not increase plasma HO‐1 protein concentration or venous monocyte HO‐1 activity in healthy humans.
The Use of a Specific Electric Board in Rehabilitation of the Aphasic Patient
Keith, Robert L. , Darley, Frederic L.

Journal of Speech and Hearing Disorders | July 29, 2014 | Volume: 32 | Issue: 2 | Pages: 148-153

10.1044/jshd.3202.148 | PMID 6024314 Get It

Early Motor Unit Disease Masquerading as Psychogenic Breathy Dysphonia: A Clinical Case Presentation
Aronson, Arnold

Journal of Speech and Hearing Disorders | July 29, 2014 | Volume: 36 | Issue: 1 | Pages: 115-124

10.1044/jshd.3601.115 | PMID 5573257 Get It

This is a study of a 20-year-old girl who developed mild, breathy dysphonia which, because of its nonspecificity, had been previously diagnosed as psychogenic; in actuality her voice change was a sign of early myasthenia gravis. The case is presented to alert the clinician to the fact that voice changes can be one of the first and only signs of early neurologic disease. Differential diagnosis requires careful laryngologic, psychiatric, speech, and neurologic examinations. In this instance, the laryngologic and psychiatric examinations were nonproductive, but the speech examination elicited a marked increase in breathiness, hypernasality, and articulatory imprecision as the consequence of prolonged, effortful speaking. This finding, along with the neurologist’s demonstration of an increase in muscular strength by means of injecting edrophonium chloride (Tensilon) led to the diagnosis of myasthenia gravis. A summary of the incidence, clinical features, methods of examination, and treatment of this disease follow the case presentation.
The Efficacy of Language Rehabilitation in Aphasia
Darley, Frederic L.

Journal of Speech and Hearing Disorders | July 29, 2014 | Volume: 37 | Issue: 1 | Pages: 3-21

10.1044/jshd.3701.03 | PMID 5053943 Get It

Studies of the effect of therapy on the course of recovery from aphasia yield inconsistent results and permit no generalization to the population of aphasic patients. Future investigations of the efficacy of therapy should specify the nature of the language disorders treated, the limits of the period of spontaneous recovery, objective measurement of relevant behavioral changes, and the nature, intensity, and quality of therapy provided. In subject selection, age, educational and social status, intelligence, health, social milieu, etiology, site and extent of lesion, time lapse since onset, type of aphasia, and nonlanguage behavior characteristics should be controlled if interpretable results are to be obtained.
A Retrospective View: Aphasia
Darley, Frederic L.

Journal of Speech and Hearing Disorders | July 29, 2014 | Volume: 42 | Issue: 2 | Pages: 161-169

10.1044/jshd.4202.161 | PMID 323577 Get It

Spastic Dysphonia. I. Voice, Neurologic, and Psychiatric Aspects
Brown, Joe R., Litin, Edward M., Aronson, Arnold , PEARSON, JOHN S.

Journal of Speech and Hearing Disorders | July 29, 2014 | Volume: 33 | Issue: 3 | Pages: 203-218

10.1044/jshd.3303.203 | PMID 4385966 Get It

Spastic Dysphonia. II. Comparison with Essential (Voice) Tremor and Other Neurologic and Psychogenic Dysphonias
Brown, Joe R., Litin, Edward M., Aronson, Arnold , PEARSON, JOHN S.

Journal of Speech and Hearing Disorders | July 29, 2014 | Volume: 33 | Issue: 3 | Pages: 219-231

10.1044/jshd.3303.219 | PMID 5668051 Get It